CA1107646A - Compose anti-microbien - Google Patents

Compose anti-microbien

Info

Publication number
CA1107646A
CA1107646A CA299,788A CA299788A CA1107646A CA 1107646 A CA1107646 A CA 1107646A CA 299788 A CA299788 A CA 299788A CA 1107646 A CA1107646 A CA 1107646A
Authority
CA
Canada
Prior art keywords
glucanase
physarum
beta
extract
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA299,788A
Other languages
English (en)
Inventor
David A.L. Davies
Anthony M.S. Pope
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of CA1107646A publication Critical patent/CA1107646A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01108—Lactase (3.2.1.108)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021—Beta-glucosidase (3.2.1.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01025—Beta-mannosidase (3.2.1.25), i.e. mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01052—Beta-N-acetylhexosaminidase (3.2.1.52)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01058—Glucan 1,3-beta-glucosidase (3.2.1.58)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01073—Licheninase (3.2.1.73)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01075—Glucan endo-1,6-beta-glucosidase (3.2.1.75)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01084—Glucan 1,3-alpha-glucosidase (3.2.1.84), i.e. mutanase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA299,788A 1977-03-28 1978-03-28 Compose anti-microbien Expired CA1107646A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB12919/77A GB1576891A (en) 1977-03-28 1977-03-28 Antimicrobial compositions containing extracts of light enzymes from physarum species
GB12919/77 1977-03-28

Publications (1)

Publication Number Publication Date
CA1107646A true CA1107646A (fr) 1981-08-25

Family

ID=10013545

Family Applications (1)

Application Number Title Priority Date Filing Date
CA299,788A Expired CA1107646A (fr) 1977-03-28 1978-03-28 Compose anti-microbien

Country Status (20)

Country Link
JP (1) JPS542310A (fr)
AT (1) AT363589B (fr)
AU (1) AU519066B2 (fr)
BE (1) BE865369A (fr)
CA (1) CA1107646A (fr)
DE (1) DE2813282A1 (fr)
DK (1) DK134678A (fr)
ES (1) ES468236A1 (fr)
FI (1) FI780933A (fr)
FR (1) FR2385730A1 (fr)
GB (1) GB1576891A (fr)
GR (1) GR71706B (fr)
IE (1) IE46698B1 (fr)
IL (1) IL54364A0 (fr)
NL (1) NL7803291A (fr)
NO (1) NO781035L (fr)
NZ (1) NZ186783A (fr)
PT (1) PT67826B (fr)
SE (1) SE7803456L (fr)
ZA (1) ZA781758B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2569107A1 (fr) * 1984-08-17 1986-02-21 Squibb & Sons Inc Suppositoires antifongiques adhesifs a longue duree

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58134014A (ja) * 1982-02-03 1983-08-10 Rooto Seiyaku Kk 義歯洗浄用組成物
JPH0261163A (ja) * 1988-08-27 1990-03-01 Hisaka Works Ltd 繊維材料取り出し方法およびそれに用いる装置
JPH0261164A (ja) * 1988-08-27 1990-03-01 Hisaka Works Ltd 処理槽への内槽装填・取り出し方法およびそれに用いる移載車。
AU3257397A (en) * 1996-06-07 1998-01-07 Gist-Brocades B.V. Antifungal compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2569107A1 (fr) * 1984-08-17 1986-02-21 Squibb & Sons Inc Suppositoires antifongiques adhesifs a longue duree

Also Published As

Publication number Publication date
GR71706B (fr) 1983-06-21
DK134678A (da) 1978-09-29
FI780933A (fi) 1978-09-29
AU3447978A (en) 1979-09-27
GB1576891A (en) 1980-10-15
SE7803456L (sv) 1978-09-29
NZ186783A (en) 1980-12-19
ES468236A1 (es) 1978-12-01
IL54364A0 (en) 1978-06-15
PT67826A (en) 1978-04-01
IE46698B1 (en) 1983-08-24
ZA781758B (en) 1979-05-30
AT363589B (de) 1981-08-10
JPS542310A (en) 1979-01-09
NL7803291A (nl) 1978-10-02
NO781035L (no) 1978-09-29
FR2385730B1 (fr) 1981-07-10
AU519066B2 (en) 1981-11-05
PT67826B (en) 1979-09-27
FR2385730A1 (fr) 1978-10-27
BE865369A (fr) 1978-09-28
IE780623L (en) 1978-09-28
ATA215978A (de) 1981-01-15
DE2813282A1 (de) 1978-10-12

Similar Documents

Publication Publication Date Title
US4062941A (en) Method for treating fungal infections using cell lytic enzymes
Dubos et al. Studies on a bactericidal agent extracted from a soil bacillus: III. Preparation and activity of a protein-free fraction
KR101736790B1 (ko) 바실러스, 히알루론산 효소, 및 그의 용도
CA1107646A (fr) Compose anti-microbien
US4144327A (en) Antimicrobial composition comprising lytic enzymes from physarum and an antimycotic agent
EP0964685B1 (fr) Composition et procede permettant de traiter les mycoses chez les animaux
Sheu et al. Cytotoxicity of rabbit macrophage peptides MCP-1 and MCP-2 for mouse tumor cells
EP0201332B1 (fr) Composé ayant une activité contre les infections
Kligman et al. In vitro and in vivo activity of candicidin on pathogenic fungi
US4328313A (en) Method of producing a plaque dispersing enzyme
WO1999058650A1 (fr) Enzymes lytiques utiles pour le traitement des infections fongiques
Goitein et al. Penetration of parenterally administered gentamicin into the cerebrospinal fluid in experimental meningitis
JPH0662426B2 (ja) 腫瘍の血管新生を抑制するための治療薬
US3987164A (en) Method for prevention of pseudomonas aeruginosa infections
Callow et al. Licheniformin, an antibiotic substance from Bacillus licheniformis, active against Mycobacterium tuberculosis
Louie et al. Relationship between Candida albicans epidermolytic proteinase activity and virulence in mice
RU2233171C2 (ru) ПОЛИФУНКЦИОНАЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ L-ЛИЗИН-α-ОКСИДАЗЫ ИЗ ГРИБА РОДА TRICHODERMA И СПОСОБ ПОЛУЧЕНИЯ ЭТОГО ФЕРМЕНТА
Agrawal et al. Antibacterial and fibrinolytic potential of Himalayan soft gold mushroom Cordyceps sinensis
JPH0559082A (ja) アロサミジン化合物及びその製造法
Eastridge JR et al. L-form infection of the rat kidney: effect of water diuresis
Emmart et al. The tuberculostatic action of Nocardia extracts in white mice
Douglas The surface layers of Candida albicans and their relevance to pathogenicity
KR920005685B1 (ko) 유산균을 이용한 항 종양제
de Lomas et al. Chemotherapy of Aspergillus fumigatus keratitis: an experimental study
Shadomy et al. In-vivo-Untersuchungen mit Sisomicin, Gentamicin und Tobramycin

Legal Events

Date Code Title Description
MKEX Expiry
MKEX Expiry

Effective date: 19980825